http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-115796-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e51d4fc6f568a1cda94894839688cab |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P60-21 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05C9-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N57-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05G3-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05C9-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C05C9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C05G3-90 |
| filingDate | 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-115796-A1 |
| titleOfInvention | STABLE LOW TEMPERATURE FORMULATIONS OF COMPOSITIONS CONTAINING UREASE INHIBITORS |
| abstract | Claim 1: A formulation comprising: (i) a urease inhibitor adduct comprising a urease inhibitor with urea, formaldehyde, or both, urea and formaldehyde; and (ii) a urease inhibitor, wherein the composition has a freezing point ranging from -20 ° C to 0 ° C. Claim 2: The formulation of claim 1, wherein the composition does not contain N-methyl-2-pyrrolidone (NMP). Claim 3: The formulation of claim 1, wherein the urease inhibitor is selected from N- (n-butyl) thiophosphoric triamide, N- (n-butyl) phosphoric triamide, N- (n-propyl) thiophosphoric triamide, N- (n-propyl) phosphoric triamide, thiophosphoryl triamide, phenyl phosphorodiamidate, cyclohexyl phosphoric triamide, cyclohexyl thiophosphoric triamide, phosphoric triamide, hydroquinone, N- (2-nitrophenyl) phosphoric triamide, N- (2-thiophosphoric triamide) , N-phenylphosphoric triamide, 1,1,3,3,3-pentaamino-1l5, 3l5-diphosphaz-2-ene, p-benzoquinone, hezamidocyclotriphosphazene, thiopyridines, thiopyrimidines, oxides-N-thiopyridine, N, N-dihalo- 2-imidazolinone, N-halo-2-oxazolidinone, phenylphosphorodiamidate (PPD / PPDA), hydroquinone, triamide N- (2-nitrophenyl) phosphoric acid (2-NPT), ammonium thiosulfate (ATS), organophosphorous urea analogs , and derivatives and combinations thereof. Claim 13: A method of improving the low temperature stability of a urease inhibitor formulation comprising providing one or more urease inhibitor adducts comprising a urease inhibitor with urea, formaldehyde, or both, urea and formaldehyde to an inhibitor of urease and solvent. |
| priorityDate | 2018-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.